Kenadion
Kenadion contains Phytomenadione (Vitamin K1), an essential nutrient required for the hepatic synthesis of active blood clotting factors (Factors II, VII, IX, and X). It is critical in preventing and treating hemorrhagic conditions caused by coagulation factor deficiencies or anticoagulant therapy.
Dosage by Body Weight
Dosage must be individualized based on the severity of the bleeding disorder, age, and clinical response. Typically administered intramuscularly, subcutaneously, or via slow intravenous infusion.
- Body Weight
- Below 5 kg
- Dose
- 0.5 mg to 1 mg
- Frequency
- Single dose at birth or as prescribed
- Tracking Notes
- Commonly administered intramuscularly to newborns for prophylaxis of hemorrhagic disease.
- Body Weight
- 5-7 kg
- Dose
- 1 mg to 2 mg
- Frequency
- Single dose or as directed by physician
- Tracking Notes
- Dose adjusted based on coagulation status and INR monitoring.
- Body Weight
- 8-10 kg
- Dose
- 2 mg to 2.5 mg
- Frequency
- Single dose or as directed by physician
- Tracking Notes
- Monitor prothrombin time (PT) / INR to guide therapy.
- Body Weight
- 11-15 kg
- Dose
- 2.5 mg to 5 mg
- Frequency
- Single dose or as directed by physician
- Tracking Notes
- Usually adjusted according to the clinical severity of the bleeding.
- Body Weight
- 16-20 kg
- Dose
- 5 mg
- Frequency
- Single dose or as directed by physician
- Tracking Notes
- Do not exceed recommended pediatric limits without specialist guidance.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | 0.5 mg to 1 mg | Single dose at birth or as prescribed | Commonly administered intramuscularly to newborns for prophylaxis of hemorrhagic disease. |
| 5-7 kg | 1 mg to 2 mg | Single dose or as directed by physician | Dose adjusted based on coagulation status and INR monitoring. |
| 8-10 kg | 2 mg to 2.5 mg | Single dose or as directed by physician | Monitor prothrombin time (PT) / INR to guide therapy. |
| 11-15 kg | 2.5 mg to 5 mg | Single dose or as directed by physician | Usually adjusted according to the clinical severity of the bleeding. |
| 16-20 kg | 5 mg | Single dose or as directed by physician | Do not exceed recommended pediatric limits without specialist guidance. |
Formulation
Purpose
Prevention and treatment of bleeding due to vitamin K deficiency, hemorrhagic disease of the newborn, or reversal of oral anticoagulant (warfarin) effects.
Generic Name
PhytomenadioneScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.